Home Serum melatonin levels in psoriasis and associated depressive symptoms
Article
Licensed
Unlicensed Requires Authentication

Serum melatonin levels in psoriasis and associated depressive symptoms

  • Lakshmi Bhuvaneshwaran Kartha , Laxmisha Chandrashekar EMAIL logo , Medha Rajappa , Vikas Menon , Devinder Mohan Thappa and Palghat Hariharan Ananthanarayanan
Published/Copyright: January 9, 2014

Received: 2013-11-6
Accepted: 2013-12-4
Published Online: 2014-1-9
Published in Print: 2014-6-1

©2014 by Walter de Gruyter Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Quo vadis, biomarkers?
  4. Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research
  5. Reviews
  6. Tracing a roadmap for vitamin B12 testing using the health technology assessment approach
  7. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis
  8. Perspectives
  9. Present and future of cancer biomarkers
  10. Opinion Paper
  11. A repository for “rare” tumor markers?
  12. Genetics and Molecular Diagnostics
  13. Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test® no-call in the clinical setting
  14. General Clinical Chemistry and Laboratory Medicine
  15. Tighter precision target required for lactate testing in patients with lactic acidosis
  16. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population
  17. Validation of a point-of-care (POC) lactate testing device for fetal scalp blood sampling during labor: clinical considerations, practicalities and realities
  18. Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests
  19. Evaluation of clinical cases in External Quality Assessment Scheme (EQAS) for the urinary sediment
  20. N Latex FLC serum free light-chain assays in patients with renal impairment
  21. A new high-sensitive nephelometric method for assaying serum C-reactive protein based on phosphocholine interaction
  22. A sensitive chemiluminescence imaging immunoassay for simultaneous detection of serum oxidized lipoprotein(a) and low density lipoprotein
  23. Quantification of teicoplanin in plasma by LC-MS with online sample clean-up and comparison with QMS® assay
  24. Cancer Diagnostics
  25. An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requests
  26. Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma
  27. Cardiovascular Diseases
  28. The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature
  29. Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments
  30. Infectious Diseases
  31. Serum miR-122 levels are related to coagulation disorders in sepsis patients
  32. Letter to the Editors
  33. Effect of storage conditions and freeze/thaw cycles on serum and plasma levels of anti-acetylcholine receptor (AChR) antibody
  34. Enzymatic isotope dilution mass spectrometry (IDMS) traceable serum creatinine is preferable over Jaffe in neonates and young infants
  35. Vitamin D, atopy, immunity
  36. 25-Hydroxy vitamin D levels in chronic urticaria and its correlation with disease severity from a tertiary care centre in South India
  37. High prevalence of anti-thyroid antibodies associated with a low vitamin D status in a pediatric cohort
  38. Serum melatonin levels in psoriasis and associated depressive symptoms
  39. Congress Abstracts
  40. ISMD2014 Tenth International Symposium on Molecular Diagnostics
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2013-0957/html
Scroll to top button